NCT06953349Recruiting
Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis
Barnet Dulaney Perkins Eye Centers
Start Date
3/31/2025
Completion Date
12/31/2025
Summary
Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
Detailed Description
The use of combination Phacoemulsification, OMNI Canaloplasty and Hydrus microstent successfully lowers IOP in ethnically-diverse patients with Open Angle Glaucoma
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
* Subjects with h/o CEIOL/OMNI/Hydrus (chosen based on subjects on more than 1 medication pre-operatively) with at least 3 years of follow up data
* have Glaucoma
Exclusion Criteria:
* Patients with angle closure glaucoma or secondary forms of glaucoma due to neovascularization of the angle, uveitic glaucoma, congenital glaucoma, or glaucoma due to congenital anomalies.
* Patients with refractory CME or CME persisting 3 months or more post-operatively
* Patients with incomplete IOP, medication logs or VF data within post-operative period
* Prior incisional surgery or MIGS
Interventions
PROCEDURE
Real-World efficacy of Hydrus Microstent with OMNI Surgical System in combination with Phacoemulsification: a retrospective analysis
Conditions
Open-Angle Glaucoma
Locations
Barnet Dulaney Perkins Eye Center
Mesa, Arizona 85206
United States